Clinical forecasting is now leveraging innovative informatics capabilities for more precise recruitment and endpoint projections during a study’s crucial…


Shareholders sue struggling Perrigo for 'misleading' them away from Mylan buy

With new CEO’s dealmaking and price-hiking past, can Valeant change its spots?

Perrigo up for $20B sale to mystery U.K. buyer: report

Valeant investors fret as new Perrigo CEO slams Papa's performance

Valeant close to announcing Perrigo's Papa as new CEO: WSJ